Background: Intravenous injection of mesenchymal and hematopoietic stem cells (MSCs, HSCs) has the disadvantages of low delivery rate to bone marrow and sequestration of cells in the lung and liver. This study was designed to determine whether there is a relationship between the administration route and dosage of stem cells and GVHD and survival. Methods: MSCs were retrieved from five subcultured C3H/10T1/2, cell lines from C3H/He mice. HSCs were transplanted by injecting 1×10 7 of bone marrow mononuclear cells and 5×10 6 of spleen cells from six to eight week old female C3H/He mice into six week old irradiated female BALB/c mice. The groups were divided into intravenous injection (IV) and intra-marrow (IM) injection groups. IV and IM+MSC groups consisted of mice transplanted with the same bone marrow mononuclear cells and SP, IV and IM groups, with the additional co-injection of 1×10 6 MSCs.
(IV group, 1×10 7 bone marrow mononuclear cells and 3×10 7 spleen cells intravenously co-injection; IV+MSC group, IV group+1×10 6 MSC intravenously co-injection; IM group, 1×10 7 bone marrow mononuclear cells and 3×10 7 spleen cells intra-marrow co-injection; IM+MSC group, IM group+1×10 6 MSC intra-marrow co-injection). MSC, mesenchymal stem cell.
Fig. 3.
Skin and small intestine pathology in BALB/c mouse on 4 days and 8 days after allogenic hematopoietic stem cell transplantation (H&E stain). Skin and small intestine were harvested and prepared for microscopic analysis as described in materials and methods. Interstitial inflammation is observed involving epithelium, mucosae, vessels, parenchyma, and luminal structures on the post transplantation 8 day comparing to the 4th day. Predominantly mononuclear infiltrates and destructions of mucosae and epithelium are also observed. )군에서 향상된 생존율을 보여주었다 (Fig. 5, P＜0.01) . (Fig. 7, P＜0.01 
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